7.62
+0.11
+(1.46%)
At close: April 17 at 4:00:01 PM EDT
7.62
0.00
(0.00%)
After hours: April 17 at 4:20:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Operating Cash Flow
-54,681
-54,681
-31,978
-23,122
Investing Cash Flow
-160,595
-160,595
-30,927
-11,411
Financing Cash Flow
234,104
234,104
69,218
46,063
End Cash Position
49,351
49,351
30,523
24,210
Capital Expenditure
-874
-874
-129
-441
Issuance of Capital Stock
238,042
238,042
68,509
36,491
Issuance of Debt
--
--
--
10,000
Free Cash Flow
-55,555
-55,555
-32,107
-23,563
12/31/2022 - 9/13/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
UPB Upstream Bio, Inc.
8.78
+4.28%
ZBIO Zenas BioPharma, Inc.
8.92
+7.08%
AARD Aardvark Therapeutics, Inc. Common Stock
7.00
-7.53%
BCAX Bicara Therapeutics Inc.
12.16
+3.40%
SEPN Septerna, Inc.
5.90
-1.50%
TYRA Tyra Biosciences, Inc.
8.92
+3.60%
RAPP Rapport Therapeutics, Inc.
10.15
+4.00%
DNTH Dianthus Therapeutics, Inc.
19.50
+2.74%
ALMS Alumis Inc.
5.0000
-1.38%
MAZE Maze Therapeutics, Inc.
8.41
+2.81%